MedTrace Logo

Immune Response Study of Influenza Vaccine

NCT01310374 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2013-07-10

No results posted yet for this study

Summary

An observational clinical study will be performed in subjects aged 12-60 years old to describe the dynamic changes of humoral immune/cellular immunity after vaccination of influenza vaccine, and to discuss the role of different antibodies against influenza virus infection, and to look for possible factors related to side effects with the vaccine.

Conditions

  • Influenza Vaccine Allergy
  • Cell Mediated Reaction

Sponsors & Collaborators

  • Centers for Disease Control and Prevention, China

    lead OTHER_GOV

Principal Investigators

  • jiang wu, Bachelor · Beijing Centers for Disease Control and Prevention

Eligibility

Min Age
12 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-05-31
Completion
2012-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01310374 on ClinicalTrials.gov